CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma

CD24 and its ligand Siglec-10 were described as an innate immune checkpoint in carcinoma. Here, we investigated this axis in B-cell lymphoma by assessing CD24 expression and evaluating pro-phagocytic effects of CD24 antibody treatment in comparison to hallmark immune checkpoint CD47. In mantle cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Freile, Jimena Álvarez, Ustyanovska Avtenyuk, Natasha, Corrales, Macarena González, Lourens, Harm Jan, Huls, Gerwin, van Meerten, Tom, Cendrowicz, Ewa, Bremer, Edwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138264/
https://www.ncbi.nlm.nih.gov/pubmed/35625912
http://dx.doi.org/10.3390/biomedicines10051175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138264/
https://www.ncbi.nlm.nih.gov/pubmed/35625912
http://dx.doi.org/10.3390/biomedicines10051175

Ejemplares similares